| #1 | | | Istanbul, Turkey | | 26+ years | Umbilical cord stem cell therapy | — | — | International Organization for Standardization, Joint Commission International |
| #2 | | | Bangkok, Thailand | | 34+ years20,000+ treatments | Intravenous (IV) injection of 50 million mesenchymal stem cells, direct injection to affected joints | Postoperative healing and joint pain | Offers a combination of IV and direct stem cell injections for targeted healing. Clinic is accredited by the Royal College of Surgeons Thailand. Doctors have performed 20,000+ procedures with personalized treatment plans. | Royal College of Surgeons Thailand |
| #3 | | | Istanbul, Turkey | | 17+ years | Umbilical cord stem cell therapy | — | — | Joint Commission International |
| #4 | | | Phuket, Thailand | | 4+ years | Umbilical cord stem cell therapy | — | — | — |
| #5 | | | Playa del Carmen, Mexico | | 7+ years | Regenerative medicine, minimally invasive treatments | Tissue restoration and healing | Specializes in regenerative medicine with minimally invasive treatments for healing and tissue restoration. Offers personalized care including home medical services. | — |
| #6 | | | Cancún, Mexico | | 9+ years | Umbilical cord stem cell therapy | — | — | — |
| #7 | | | Puerto Vallarta, Mexico | | 6+ years | Umbilical cord stem cell therapy, mesenchymal stem cell protocols | Autism-related challenges | Specializes in regenerative medicine with 15+ years experience. Uses mesenchymal stem cells to target neuroinflammation. Doctors have performed 900+ treatments with 98% patient recommendation rate. | Consejo de Salubridad General |
| #8 | | | Istanbul, Turkey | | 14+ years | Umbilical cord stem cell therapy | — | — | Joint Commission International , Patient choice in Pediatric Oncology & Hematology Oncology |
| #9 | | | Bangkok, Thailand | | 71+ years | Umbilical cord stem cell therapy | — | — | ISO 9001:2015 Quality management systems |
| #10 | | | Barcelona, Spain | | 32+ years23,000+ treatments | Cultured mesenchymal stem cell therapy, regenerative medicine with cultured mesenchymal stem cells | Degenerative joint and spine conditions | Pioneers in delivering >250 million cultured stem cells per treatment. Published Phase I-II trial results show efficacy in knee osteoarthritis. 300+ patients treated worldwide with this protocol. | Joint Commission International , European Foundation for Quality Management |